Abstract
Patients implanted with Spinal Cord Stimulation (SCS) devices can exhibit mixed pain (nociceptive: pain derived from non-neuronal tissue and nociceptor activation; or, neuropathic: pain derived from lesion or disease that satisfies established neurological diagnostic criteria), but may present as challenging cases given the potential heterogenous manifestation of their symptoms. A recent study now reports the discovery of a novel SCS methodology (FAST) capable of delivering therapeutic neurostimulation using a biphasic-symmetric waveform based on active recharge, sub-perception SCS that is capable of inducing analgesia within minutes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
